Playback speed×Share postShare post at current timeShare from 0:000:00/1842What do sweeping U.S. tariffs have to do with biotech, women’s health or innovation strategy? Maryann SelfeApr 06, 20251842ShareTranscriptIn this short video, I unpack the deeper signal behind today’s article and why smart founders and investors are rethinking where to build next. Would love to hear what you are seeing. Drop me a comment. Discussion about this videoCommentsRestacksThe Billion Dollar Blindspot reply rulesThe Billion Dollar BlindspotSubscribeAuthorsMaryann SelfeRecent PostsMenopause: What's Science, What's Hype, and Who Can You Trust? | Live with Dr Deepti GandhiNov 15 • Maryann Selfe and Midlife RUMInationsWhy Great Healthcare Ideas Still FailAug 30 • Maryann SelfeThe Menopause Information CrisisApr 16 • Maryann Selfe and Hotflash IncBuilding FemTech Infrastructure in AsiaApr 2 • Maryann SelfeBefore Venture Shows Up | How Catalytic Capital Creates Women’s Health MarketsMar 12 • Maryann SelfeWhy It Takes Years to Build in Women’s HealthFeb 26 • Maryann SelfeWhy Women’s Heart Disease Is Still MisdiagnosedJan 29 • Maryann SelfeHow Hormones Change Women’s Hearts and Why Cardiology Wasn’t Built to See ItJan 15 • Maryann Selfe